Canada Markets closed

BriaCell Therapeutics Corp. (BCTX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.4700-0.4700 (-9.51%)
At close: 04:00PM EDT
4.4900 +0.02 (+0.45%)
After hours: 07:59PM EDT
Currency in USD

Valuation Measures4

We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.51
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 312.4700
52 Week Low 32.8200
50-Day Moving Average 38.0720
200-Day Moving Average 37.8677

Share Statistics

Avg Vol (3 month) 3876.24k
Avg Vol (10 day) 3437.81k
Shares Outstanding 515.91M
Implied Shares Outstanding 6N/A
Float 811.73M
% Held by Insiders 125.39%
% Held by Institutions 124.84%
Shares Short (Apr 28, 2022) 41.87M
Short Ratio (Apr 28, 2022) 41.15
Short % of Float (Apr 28, 2022) 4N/A
Short % of Shares Outstanding (Apr 28, 2022) 412.26%
Shares Short (prior month Mar 30, 2022) 41.94M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 01, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:300
Last Split Date 3Jan 01, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 30, 2021
Most Recent Quarter (mrq)Jan 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-32.19%
Return on Equity (ttm)-27.28%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -12.6M
Net Income Avi to Common (ttm)-6.02M
Diluted EPS (ttm)-0.2940
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)47.98M
Total Cash Per Share (mrq)3.14
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)79.84
Book Value Per Share (mrq)3.60

Cash Flow Statement

Operating Cash Flow (ttm)-11.87M
Levered Free Cash Flow (ttm)-7.27M